Hospital-level Variation in the Management of Blood Pressure and Low-density Lipoprotein in the Outpatient Hypertensives in China-a Cross Sectional Study

NCT ID: NCT03862183

Last Updated: 2019-03-05

Basic Information

• Recruitment Status: UNKNOWN
• Total Enrollment: 21000 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2017-07-01
• Study Completion Date: 2020-12-30

Brief Summary

To investigate the proportion, medication use and control rate of metabolic abnormalities such as dyslipidemia in outpatients with hypertension in different levels of hospitals in China. To investigate the gap between guidelines and clinical practices, and analyze the cause. we also set up a continuing medical education program to narrow the gap and the effect of the program will be estimated.

Conditions

Hypertension; Hyperlipidemia

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

dyslipidemia in hypertension

continuing medical education program

Intervention Type: OTHER

educating all the involved doctor the same medical knowledge on hypertension control

hypertension

continuing medical education program

Intervention Type: OTHER

educating all the involved doctor the same medical knowledge on hypertension control

Interventions

continuing medical education program

educating all the involved doctor the same medical knowledge on hypertension control

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

1. Outpatients from departments of Cardiology, Endocrinology, Nephrology, Neurology, Geriatrics or General Internal Medicine.

2. Diagnosed as hypertension. Diagnostic criteria: 1)The office BP measured at the day of visit and at least one time before that day were above the cut-off values ( ≥140 mmHg SBP and/or ≥90 mmHg DBP); 2)for patients with normal BP at the day of visit, they should have already been given pre-treatment with antihypertensive drugs ≥ 2 weeks.

3. Voluntary participation.

Exclusion Criteria

1. Patients aged< 18 years old.

2. Patients without a definite diagnosis of hypertension（for instance, if the patient has been taking antihypertensive drugs irregularly, it is difficult to confirm the diagnosis of hypertension）.

3. Patients with a definite diagnosis of secondary hypertension.

4. Patients are diagnosed dyslipidemia with clear cause, such as nephrotic syndrome, severe hypothyroidism, terminal stage of malignancy, etc.

5. Patients are diagnosed end-stage renal disease, hemodialysis, and peritoneal dialysis patients.

6. Patients diagnosed with mental abnormalities who are unable to complete the questionnaire.

7. Patients have once participated in this research during this study cycle（to avoid repeated participation）.

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 85 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Huashan Hospital

OTHER

Sponsor Role: lead

Responsible Party

Yong Li

associate chief of the cardiology department

Responsibility Role: PRINCIPAL_INVESTIGATOR

Locations

Cardiology Department in Huashan Hospital

Shanghai, Shanghai Municipality, China

Site Status: RECRUITING

Countries

China

Central Contacts

xiufang gao, PhD

Role: CONTACT

sophiakao@126.com

+86 13788908071

Facility Contacts

Xiufang Gao, PhD

Role: primary

References

Xie K, Gao X, Bao L, Shan Y, Shi H, Li Y. The different risk factors for isolated diastolic hypertension and isolated systolic hypertension: a national survey. BMC Public Health. 2021 Sep 14;21(1):1672. doi: 10.1186/s12889-021-11686-9.

Reference Type: DERIVED

PMID: 34521364 (View on PubMed)

Other Identifiers

UPPDATE

Identifier Type: -

Identifier Source: org_study_id